이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Auxly Cannabis Group 미래 성장

Future 기준 확인 0/6

현재 Auxly Cannabis Group 의 성장과 수익을 예측할 만큼 분석가의 범위가 충분하지 않습니다.

주요 정보

n/a

수익 성장률

n/a

EPS 성장률

Pharmaceuticals 수익 성장	74.4%
매출 성장률	n/a
향후 자기자본 수익률	n/a
애널리스트 커버리지	None
마지막 업데이트	n/a

최근 미래 성장 업데이트

Recent updates

Market Cool On Auxly Cannabis Group Inc.'s (TSE:XLY) Revenues Pushing Shares 40% Lower

Jun 19

Does Auxly Cannabis Group (TSE:XLY) Have A Healthy Balance Sheet?

Apr 27

A Piece Of The Puzzle Missing From Auxly Cannabis Group Inc.'s (TSE:XLY) 33% Share Price Climb

Mar 21

Auxly Cannabis Group Inc. (TSE:XLY) Stock Rockets 33% But Many Are Still Ignoring The Company

Feb 03

Take Care Before Jumping Onto Auxly Cannabis Group Inc. (TSE:XLY) Even Though It's 38% Cheaper

Dec 19

The Consensus EPS Estimates For Auxly Cannabis Group Inc. (TSE:XLY) Just Fell Dramatically

Aug 11

Health Check: How Prudently Does Auxly Cannabis Group (TSE:XLY) Use Debt?

Jul 21

Growth Investors: Industry Analysts Just Upgraded Their Auxly Cannabis Group Inc. (TSE:XLY) Revenue Forecasts By 8.2%

Aug 18

Auxly Cannabis Group Inc. (TSE:XLY) Just Reported And Analysts Have Been Cutting Their Estimates

Apr 29

Breakeven On The Horizon For Auxly Cannabis Group Inc. (CVE:XLY)

Mar 24

A Look At Auxly Cannabis Group's (CVE:XLY) Share Price Returns

Jan 28

이 섹션에서는 일반적으로 투자자가 회사의 수익 창출 능력을 이해하는 데 도움이 되도록 전문 애널리스트의 컨센서스 추정치를 기반으로 수익 및 수익 성장 전망치를 제시합니다. 하지만 Auxly Cannabis Group 은 충분한 과거 데이터를 제공하지 않았고 애널리스트 예측도 없기 때문에 과거 데이터를 추정하거나 애널리스트 예측을 사용하여 미래 수익을 안정적으로 계산할 수 없습니다.

SimplyWall St에서 다루는 기업의 97%가 과거 재무 데이터를 가지고 있기 때문에 이는 매우 드문 상황입니다.

수익 및 매출 성장 예측

TSX:XLY - 애널리스트의 미래 추정치 및 과거 재무 데이터 (CAD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
3/31/2024	102	-60	1	3	N/A
12/31/2023	101	-45	7	8	N/A
9/30/2023	99	-7	0	6	N/A
6/30/2023	90	-99	-8	1	N/A
3/31/2023	96	-101	-1	8	N/A
12/31/2022	94	-130	-12	-2	N/A
9/30/2022	99	-133	-21	-22	N/A
6/30/2022	104	-86	-23	-26	N/A
3/31/2022	97	-75	-38	-38	N/A
12/31/2021	84	-46	-50	-50	N/A
9/30/2021	73	-53	-51	-44	N/A
6/30/2021	61	-57	-57	-43	N/A
3/31/2021	46	-81	-53	-39	N/A
12/31/2020	47	-84	-54	-33	N/A
9/30/2020	32	-116	-82	-52	N/A
6/30/2020	21	-115	-93	-59	N/A
3/31/2020	17	-102	-109	-73	N/A
12/31/2019	8	-103	-113	-79	N/A
9/30/2019	5	-80	-89	-71	N/A
6/30/2019	4	-72	-87	-66	N/A
3/31/2019	1	-70	-78	-55	N/A
12/31/2018	1	-67	-61	-44	N/A
9/30/2018	2	-41	-42	-29	N/A
6/30/2018	2	-38	-33	-25	N/A
3/31/2018	3	-27	-19	-18	N/A
12/31/2017	2	-18	N/A	-11	N/A
9/30/2017	0	-9	N/A	-9	N/A
6/30/2017	0	-3	N/A	-3	N/A
3/31/2017	0	-2	N/A	-1	N/A
12/31/2016	0	0	N/A	0	N/A
9/30/2016	0	0	N/A	0	N/A
6/30/2016	0	0	N/A	0	N/A
3/31/2016	0	0	N/A	0	N/A
12/31/2015	0	0	N/A	0	N/A
9/30/2015	0	0	N/A	0	N/A
6/30/2015	0	0	N/A	0	N/A
3/31/2015	0	0	N/A	0	N/A
12/31/2014	0	0	N/A	0	N/A
9/30/2014	0	0	N/A	0	N/A
6/30/2014	0	0	N/A	0	N/A
3/31/2014	0	0	N/A	0	N/A
12/31/2013	0	0	N/A	0	N/A
9/30/2013	0	0	N/A	0	N/A

애널리스트 미래 성장 예측

수입 대 저축률: XLY 의 예상 수익 증가율이 절약률( 2.1% )보다 높은지 판단하기에는 데이터가 부족합니다.

수익 vs 시장: XLY 의 수익이 Canadian 시장보다 빠르게 성장할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

고성장 수익: XLY 의 수익이 향후 3년 동안 상당히 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

수익 대 시장: XLY 의 수익이 Canadian 시장보다 빠르게 성장할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

고성장 수익: XLY 의 수익이 연간 20% 보다 빠르게 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: XLY 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

Auxly Cannabis Group 미래 성장

Future 기준 확인 0/6

주요 정보

최근 미래 성장 업데이트

Consensus EPS estimates fall by 47%

Consensus revenue estimates fall by 11%

Consensus EPS estimates fall by 12%

Consensus revenue estimates fall by 15%

Price target decreased to CA$0.41

Price target increased to CA$0.55

Recent updates

Market Cool On Auxly Cannabis Group Inc.'s (TSE:XLY) Revenues Pushing Shares 40% Lower

First quarter 2024 earnings released: CA$0.026 loss per share (vs CA$0.011 loss in 1Q 2023)

Auxly Cannabis Group Inc. to Report Q1, 2024 Results on May 13, 2024

Does Auxly Cannabis Group (TSE:XLY) Have A Healthy Balance Sheet?

Auxly Cannabis Group Inc., Annual General Meeting, Jun 28, 2024

New minor risk - Shareholder dilution

Full year 2023 earnings released: CA$0.045 loss per share (vs CA$0.15 loss in FY 2022)

A Piece Of The Puzzle Missing From Auxly Cannabis Group Inc.'s (TSE:XLY) 33% Share Price Climb

Auxly Cannabis Group Inc. to Report Q4, 2023 Results on Mar 25, 2024

Auxly Cannabis Group Inc. (TSE:XLY) Stock Rockets 33% But Many Are Still Ignoring The Company

Take Care Before Jumping Onto Auxly Cannabis Group Inc. (TSE:XLY) Even Though It's 38% Cheaper

Third quarter 2023 earnings released: EPS: CA$0.033 (vs CA$0.067 loss in 3Q 2022)

Auxly Cannabis Group Inc. to Report Q3, 2023 Results on Nov 13, 2023

Insufficient new directors

New major risk - Market cap size

Does Auxly Cannabis Group (TSE:XLY) Have A Healthy Balance Sheet?

New major risk - Financial position

Second quarter 2023 earnings released: CA$0.013 loss per share (vs CA$0.016 loss in 2Q 2022)

Auxly Cannabis Group Inc. to Report Q2, 2023 Results on Aug 14, 2023

Auxly Cannabis Group Inc. Announces Executive Changes

Is Auxly Cannabis Group (TSE:XLY) Using Debt In A Risky Way?

First quarter 2023 earnings released: CA$0.011 loss per share (vs CA$0.047 loss in 1Q 2022)

Auxly Cannabis Group Inc. to Report Q1, 2023 Results on May 15, 2023

Auxly Cannabis Group Inc. (TSE:XLY) Could Be Riskier Than It Looks

Full year 2022 earnings released: CA$0.15 loss per share (vs CA$0.059 loss in FY 2021)

Auxly Cannabis Group Inc. announced that it has received CAD 3.36 million in funding

Auxly Cannabis Group Inc. announced that it expects to receive CAD 3.36 million in funding

Morganti & Co. Issues Auxly Cannabis Group, Inc. Shareholder Class Action Notice of Certification

Consensus EPS estimates fall by 47%

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Auxly Cannabis Group Inc. to Report Q3, 2022 Results on Nov 14, 2022

Second quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

The Consensus EPS Estimates For Auxly Cannabis Group Inc. (TSE:XLY) Just Fell Dramatically

An unknown buyer acquired Outdoor cultivation facility located in Hortonville, Nova Scotia from Auxly Cannabis Group Inc. (TSX:XLY) for CAD 4.1 million.

Consensus revenue estimates fall by 11%

Auxly Cannabis Group Inc. to Report Q2, 2022 Results on Aug 15, 2022

Auxly Cannabis Group Inc. Introduces Edi's by Foray with the Launch of Large-Pack, Snackable Edibles

Consensus EPS estimates fall by 12%

Health Check: How Prudently Does Auxly Cannabis Group (TSE:XLY) Use Debt?

An unknown buyer acquired Auxly Annapolis Inc from Auxly Cannabis Group Inc. (TSX:XLY) for CAD 6 million.

Consensus revenue estimates fall by 15%

Auxly Cannabis Group Inc. Reports Impairment Changes for the First Quarter Ended March 31, 2022

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Auxly Cannabis Group Inc. to Report Q1, 2022 Results on May 16, 2022

Price target decreased to CA$0.41

Auxly Cannabis Group Inc., Annual General Meeting, Jun 30, 2022

Auxly Cannabis Group Inc. Announces Close of Robinsons Cultivation Facilities

KSM Securities Litigation Group Announces Ontario Court Grants Leave to Shareholders to Advance Statutory Claim Against Auxly Cannabis Securities Class Action

Price target increased to CA$0.55

Forecast to breakeven in 2024

Auxly Cannabis Group Inc. (TSX:XLY) acquired Sunens Farms Inc. from Peter Quiring for CAD 5 million.

Price target decreased to CA$0.51

Third quarter 2021 earnings released: CA$0.016 loss per share (vs CA$0.028 loss in 3Q 2020)

Price target increased to CA$0.50

Second quarter 2021 earnings released: CA$0.005 loss per share (vs CA$0.046 loss in 2Q 2020)

Growth Investors: Industry Analysts Just Upgraded Their Auxly Cannabis Group Inc. (TSE:XLY) Revenue Forecasts By 8.2%

Consensus forecasts updated

Auxly Cannabis Group Inc. on Hot Streak Heading into Summer Packed with New Products

Auxly Cannabis Group Inc. has completed a Composite Units Offering in the amount of CAD 15.0003 million.

CEO & Director recently bought CA$169k worth of stock

Consensus EPS estimates fall to -CA$0.05

Myconic Capital Corp. (DB:MY0) completed the acquisition of KGK Science Inc. from Auxly Cannabis Group Inc. (TSX:XLY).

Price target decreased to CA$0.52

Myconic Capital Corp. (DB:MY0) entered into a definitive share purchase agreement to acquire KGK Science Inc. from Auxly Cannabis Group Inc. (TSX:XLY) for CAD 16.5 million.

First quarter 2021 earnings released: CA$0.015 loss per share (vs CA$0.02 loss in 1Q 2020)

Auxly Cannabis Group Inc. announced that it has received CAD 8 million in funding

Auxly Cannabis Group Inc. announced that it expects to receive CAD 8 million in funding

Auxly Cannabis Group Inc. (TSE:XLY) Just Reported And Analysts Have Been Cutting Their Estimates

Full year 2020 earnings released: CA$0.14 loss per share (vs CA$0.17 loss in FY 2019)